• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,323
3,588
3,475
2,881
2,814

COUNTRY

2,408
900
279
269
228

CATEGORIES

  • 940
  • 179
    • 43
    • 213
    • 50
  • 182
  • 295
    • 51
  • 506
  • 227
  • 242
  • 60
  • 64
  • 868
  • 1,522
  • 823
  • 20
  • 499
  • 1,431
  • 2,411
    • 85
    • 124
    • 66
    • 65
    • 37
    • 37
    • 12
    • 12
    • 11
    • 18
  • 23
  • 270
  • 32
  • 2,637
SHOW ALL…

PRICE

2,758
7,628
17,050
30,316

PUBLISHED

2,224
3,776
12,607
30,316

PRODUCT TYPE

27,353
1,090
1,038
524
163
58
23
21
20
16
6
3
1

Pharmaceuticals

(30,316 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Moderate Pain-Pipeline Insights

This “ Moderate Pain-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Panic Disorders-Pipeline Insights

This “ Panic Disorders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Paroxysmal Nocturnal Hemoglobinuria-Pipeline Insights

This “ Paroxysmal Nocturnal Hemoglobinuria-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish...

February 2015
FROM

Growth Disorders-Pipeline Insights

This “ Growth Disorders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Guillain-Barre Syndrome-Pipeline Insights

This “ Guillain-Barre Syndrome-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Hearing Disorders-Pipeline Insights

This “ Hearing Disorders-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Helicobacter Pylori Infections-Pipeline Insights

This “ Helicobacter Pylori Infections-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the...

February 2015
FROM

Aspergillosis-Pipeline Insights

This “ Aspergillosis-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Atonic Neurogenic Bladder-Pipeline Insights

This “ Atonic Neurogenic Bladder-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Recurrent Malignant Glioma-Pipeline Insights

This “Recurrent Malignant Glioma-Pipeline Insights”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Refractory Leukemia-Pipeline Insights, 2015

This “ Refractory Leukemia-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Sarcopenia-Pipeline Insights

This “ Sarcopenia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all...

February 2015
FROM

Sciatic Pain-Pipeline Insights

This “ Sciatic Pain-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for...

February 2015
FROM

Menopausal Disorders-Pipeline Insights, 2015

This “ Menopausal Disorders-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Metabolic Syndrome-Pipeline Insights, 2015

This “ Metabolic Syndrome-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Sickle Cell Disease-Pipeline Insights, 2015

This “ Sickle Cell Disease-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Skin And Skin Structure Infections (SSSI)-Pipeline Insights, 2015

This “ Skin And Skin Structure Infections (SSSI)-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish...

February 2015
FROM

Chemotherapy Induced Anemia-Pipeline Insights

This “ Chemotherapy Induced Anemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Chemotherapy Induced Neutropenia-Pipeline Insights

This “Chemotherapy Induced Neutropenia-Pipeline Insights”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM

Hyperphosphatemia-Pipeline Insights

This “ Hyperphosphatemia-Pipeline Insights, 2014”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S